StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
68
This year
6
Publishing Date
2024 - 03 - 01
1
2024 - 02 - 16
1
2024 - 02 - 13
1
2024 - 01 - 05
1
2023 - 12 - 06
1
2023 - 11 - 27
1
2023 - 11 - 10
1
2023 - 11 - 03
1
2023 - 10 - 20
1
2023 - 10 - 17
1
2023 - 10 - 09
1
2023 - 10 - 06
1
2023 - 07 - 25
1
2023 - 05 - 30
1
2023 - 04 - 19
1
2023 - 04 - 17
1
2023 - 02 - 13
1
2022 - 11 - 17
1
2022 - 11 - 08
2
2022 - 10 - 14
1
2022 - 10 - 06
1
2022 - 09 - 22
1
2022 - 09 - 09
1
2022 - 08 - 29
1
2022 - 08 - 16
1
2022 - 08 - 15
2
2022 - 07 - 15
1
2022 - 06 - 23
1
2022 - 06 - 02
2
2022 - 05 - 18
1
2022 - 05 - 12
1
2022 - 04 - 27
1
2022 - 04 - 21
1
2022 - 03 - 18
1
2022 - 03 - 15
1
2022 - 02 - 03
1
2022 - 01 - 24
1
2022 - 01 - 19
1
2022 - 01 - 17
1
2021 - 12 - 29
1
2021 - 12 - 24
1
2021 - 12 - 06
1
2021 - 11 - 19
1
2021 - 09 - 20
1
2021 - 09 - 07
3
2021 - 08 - 18
1
2021 - 07 - 29
1
2021 - 05 - 28
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 05
1
2021 - 04 - 23
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 16
2
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 07
1
2021 - 03 - 31
1
2021 - 03 - 16
1
Sector
Commercial services
7
Communications
1
Distribution services
1
Electronic technology
4
Health services
14
Health technology
68
Manufacturing
2
N/a
1
Tags
Alliances
8
Application
4
Approval
12
Biomarkers
5
Biotech
5
Biotech-bay
11
Biotech-beach
19
Blood
7
Cancer
68
China
5
Collaboration
5
Conference
7
Covid
5
Covid-19
5
Deadline
19
Diagnostic
30
Diagnostics
46
Disease
13
Dna
9
Drug
7
Earnings
9
Europe
5
Expansion
6
Expected
8
Financial
13
Funding
6
Galleri
6
Genetic
23
Genomic
27
Genomics
17
Global
70
Growing
9
Growth
52
Health
11
In vitro
5
Innovation
5
Iot
5
Life
5
Market
138
Meeting
6
Molecular
22
Molecular diagnostics
5
Money
5
N/a
366
Partnership
6
People
10
Reach
18
Report
69
Research
59
Results
18
Services
8
Set
6
Study
6
Technology
13
Test
33
Tools
5
Treatment
7
Trends
6
Trial
6
Year
7
Entities
Abbott laboratories
12
Abbvie inc.
11
Adc therapeutics sa
5
Agilent technologies, inc.
9
Agios pharmaceuticals, inc.
10
Alignment healthcare inc
1
Alnylam pharmaceuticals, inc.
10
Amgen inc.
10
Angle plc
2
Astrazeneca plc
5
Aveo pharmaceuticals, inc.
10
Becton, dickinson and company
7
Beigene, ltd.
10
Bio-rad laboratories, inc.
9
Biocept, inc.
6
Biontech se
1
Blueprint medicines corporation
10
Boston scientific corporation
1
Bristol-myers squibb company
10
Canon inc
1
Cardinal health, inc.
1
Centogene n.v.
7
Clovis oncology, inc.
10
Conmed corporation
1
Cts corporation
1
Danaher corporation
2
Eli lilly and company
11
Epizyme, inc.
10
Exact sciences corporation
5
Exelixis, inc.
10
Fulgent genetics, inc.
1
General electric company
1
Gilead sciences, inc.
1
Glaxosmithkline plc
1
Guardant health, inc.
4
Hologic, inc.
8
Htg molecular diagnostics, inc.
3
Illumina, inc.
68
Incyte corporation
10
Invitae corporation
3
Johnson & johnson
1
Karyopharm therapeutics inc.
10
Koninklijke philips n.v.
6
Laboratory corporation of america holdings
4
Myriad genetics, inc.
13
Nanostring technologies, inc.
2
Natera, inc.
2
Opko health, inc.
4
Perkinelmer, inc.
3
Pfizer, inc.
11
Qiagen n.v.
17
Quest diagnostics incorporated
4
Regeneron pharmaceuticals, inc.
10
Rigel pharmaceuticals, inc.
10
Sanofi
11
Seagen inc.
2
Thermo fisher scientific inc
12
Veracyte, inc.
2
Verastem, inc.
10
Y-mabs therapeutics, inc.
10
Symbols
A
27
ABBV
53
ABT
49
ALPMF
50
ALPMY
50
AMGN
91
ANIX
49
ARAY
26
AVEO
24
AZN
144
AZNCF
74
BCTX
50
BDX
26
BGNE
59
BIOC
31
BMY
107
BPMC
27
CLVS
33
CSTL
28
EXAS
56
EXEL
43
FNCTF
138
GH
54
GILD
59
GLAXF
46
GNPX
26
GSK
54
GTHX
27
HOLX
32
HOTH
29
IBRX
30
ILMN
68
IMGN
25
IMMP
34
INCY
57
JAGX
37
JNJ
139
KPTI
27
LLY
139
LTRN
25
MRK
75
MRTX
32
MYGN
50
NTRA
38
NVCR
30
NVS
106
NVSEF
91
NVTA
25
ONCY
41
PDSB
35
PFE
66
QGEN
31
REGN
42
SGEN
55
SNY
217
SNYNF
167
TAK
35
TMO
51
VCYT
46
VSTM
25
Exchanges
Nasdaq
68
Nyse
36
Crawled Date
2024 - 03 - 02
1
2024 - 02 - 16
1
2024 - 02 - 13
1
2024 - 01 - 05
1
2023 - 12 - 06
1
2023 - 11 - 27
1
2023 - 11 - 10
1
2023 - 11 - 03
1
2023 - 10 - 20
1
2023 - 10 - 18
1
2023 - 10 - 09
1
2023 - 10 - 06
1
2023 - 07 - 25
1
2023 - 05 - 30
1
2023 - 04 - 19
1
2023 - 04 - 17
1
2023 - 02 - 13
1
2022 - 11 - 17
1
2022 - 11 - 08
2
2022 - 10 - 14
1
2022 - 10 - 06
1
2022 - 09 - 22
1
2022 - 09 - 09
1
2022 - 08 - 29
1
2022 - 08 - 16
1
2022 - 08 - 15
2
2022 - 07 - 15
1
2022 - 06 - 23
1
2022 - 06 - 02
2
2022 - 05 - 18
1
2022 - 05 - 12
1
2022 - 04 - 27
1
2022 - 04 - 21
1
2022 - 03 - 18
1
2022 - 03 - 15
1
2022 - 02 - 03
1
2022 - 01 - 24
1
2022 - 01 - 19
1
2022 - 01 - 17
1
2021 - 12 - 29
1
2021 - 12 - 24
1
2021 - 12 - 06
1
2021 - 11 - 19
1
2021 - 09 - 20
1
2021 - 09 - 07
3
2021 - 08 - 18
1
2021 - 07 - 29
1
2021 - 05 - 28
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 05
1
2021 - 04 - 23
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 16
2
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 07
1
2021 - 03 - 31
1
2021 - 03 - 16
1
Crawled Time
00:00
1
00:20
1
01:00
1
03:00
1
06:00
1
07:00
1
08:00
1
09:00
2
10:00
3
11:00
4
12:20
1
12:30
1
13:00
3
13:20
2
13:30
1
13:50
1
14:00
3
14:15
1
14:20
2
14:30
2
15:00
2
15:30
1
16:00
5
17:00
3
17:37
1
18:00
3
18:04
1
18:26
1
18:31
2
18:33
1
18:40
1
18:42
1
19:00
3
20:00
1
20:59
1
21:00
4
22:00
2
23:00
2
Source
www.biospace.com
19
www.fda.gov
10
www.globenewswire.com
1
www.prnewswire.com
38
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Cancer
symbols :
ILMN
save search
GRAIL Presents New Data on Galleri® and Its Methylation Platform at the Annual American Association for Cancer Research (AACR) Meeting
Published:
2024-03-27
(Crawled : 23:00)
- biospace.com/
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
-6.98%
|
O:
1.28%
H:
2.34%
C:
2.34%
galleri
association
cancer
research
meeting
platform
GRAIL Announces Novel Risk Classification Test to Be Used in Lung Cancer Study
Published:
2024-03-18
(Crawled : 13:30)
- biospace.com/
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
-2.56%
|
O:
0.51%
H:
2.49%
C:
1.37%
AZN
|
News
|
$71.26
0.58%
3.8M
|
Health Technology
|
6.85%
|
O:
-0.45%
H:
0.55%
C:
-0.24%
lung
test
cancer
risk
study
Europe Cancer Diagnostics Market Sees Promising Growth Amid Rising Demand for Precision Diagnostics - Forecasts to 2031
Published:
2024-03-01
(Crawled : 00:20)
- prnewswire.com
QGEN
|
$41.48
-0.98%
530K
|
Health Technology
|
Email alert
Add to watchlist
QGEN
|
$41.48
-0.98%
530K
|
Health Technology
|
Email alert
Add to watchlist
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
Email alert
Add to watchlist
CAJFF
|
$29.0664
-28.15%
760
|
Electronic Technology
|
Email alert
Add to watchlist
CAJPY
|
$28.73
39K
|
n/a
|
Email alert
Add to watchlist
HOLX
|
$76.98
-0.27%
340K
|
Health Technology
|
Email alert
Add to watchlist
TMO
|
News
|
$573.21
-0.24%
940K
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$106.96
-0.59%
2.6M
|
Health Technology
|
Email alert
Add to watchlist
europe
precision
cancer
diagnostics
growth
market
Liquid Biopsy Market Set to Reach US$ 10.08 Billion by 2030 with Pioneering Breakthroughs in Cancer Detection and Management
Published:
2024-02-16
(Crawled : 19:00)
- prnewswire.com
TMO
|
News
|
$573.21
-0.24%
940K
|
Health Technology
|
Email alert
Add to watchlist
EXAS
|
$64.075
0.86%
420K
|
Health Technology
|
Email alert
Add to watchlist
QGEN
|
$41.48
-0.98%
530K
|
Health Technology
|
Email alert
Add to watchlist
QGEN
|
$41.48
-0.98%
530K
|
Health Technology
|
Email alert
Add to watchlist
LH
M
|
$207.51
-0.22%
360K
|
Health Services
|
Email alert
Add to watchlist
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$148.515
-0.7%
4.3M
|
Health Technology
|
Email alert
Add to watchlist
management
reach
cancer
set
market
Clinical Biomarkers Market Analysis and Forecast, 2023-2033 - Cancer Biomarkers to Witness the Highest Growth between 2023 and 2033
Published:
2024-02-13
(Crawled : 03:00)
- prnewswire.com
TMO
|
News
|
$573.21
-0.24%
940K
|
Health Technology
|
3.4%
|
O:
-0.99%
H:
0.88%
C:
-0.52%
DGX
|
News
|
$138.13
1.05%
690K
|
Health Services
|
5.15%
|
O:
0.01%
H:
0.55%
C:
-1.66%
QGEN
|
$41.48
-0.98%
530K
|
Health Technology
|
-4.4%
|
O:
-1.64%
H:
0.58%
C:
-0.56%
BIO
|
$278.59
-2.34%
110K
|
Health Technology
|
-12.57%
|
O:
-1.32%
H:
0.37%
C:
-1.83%
BDX
|
$233.97
-0.17%
420K
|
Health Technology
|
-3.7%
|
O:
0.04%
H:
0.72%
C:
-1.81%
A
|
$137.51
-1.21%
720K
|
Health Technology
|
4.63%
|
O:
-2.03%
H:
1.0%
C:
-0.44%
ABT
|
News
|
$106.96
-0.59%
2.6M
|
Health Technology
|
-3.53%
|
O:
0.94%
H:
0.0%
C:
0.0%
QGEN
|
$41.48
-0.98%
530K
|
Health Technology
|
-4.4%
|
O:
-1.64%
H:
0.58%
C:
-0.56%
MYGN
|
$18.75
0.81%
150K
|
Health Technology
|
-19.31%
|
O:
-3.99%
H:
1.49%
C:
-3.71%
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
-11.07%
|
O:
-2.48%
H:
1.08%
C:
-2.01%
CNTG
|
$0.475
-1.04%
15K
|
Commercial Services
|
-50.26%
|
O:
2.59%
H:
0.0%
C:
-11.11%
cancer
biomarkers
growth
market
Illumina expands collaboration with Janssen to advance molecular residual disease cancer test
Published:
2024-01-05
(Crawled : 14:30)
- prnewswire.com
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
-5.3%
|
O:
-2.54%
H:
4.66%
C:
1.87%
disease
test
cancer
collaboration
molecular
Validation Data on a Novel Prognostic Test Developed by GRAIL in Stage I Lung Cancer Presented at North America Conference on Lung Cancer
Published:
2023-12-06
(Crawled : 22:00)
- biospace.com/
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
11.36%
|
O:
1.4%
H:
3.94%
C:
0.58%
AZN
|
News
|
$71.26
0.58%
3.8M
|
Health Technology
|
10.69%
|
O:
0.73%
H:
0.06%
C:
-1.38%
america
lung
conference
test
cancer
Cancer Biopsy Market Share is Expected to Reach USD 92.09 Billion By 2032, Growing at 14.8% CAGR: Polaris Market Research
Published:
2023-11-27
(Crawled : 15:30)
- prnewswire.com
TMO
|
News
|
$573.21
-0.24%
940K
|
Health Technology
|
15.7%
|
O:
0.1%
H:
0.86%
C:
0.19%
QGEN
|
$41.48
-0.98%
530K
|
Health Technology
|
2.34%
|
O:
0.37%
H:
0.46%
C:
-1.1%
PHG
|
News
|
$20.92
-0.43%
350K
|
Health Technology
|
-1.59%
|
O:
0.09%
H:
0.7%
C:
0.47%
DHR
|
$250.29
-1.11%
1.3M
|
Health Technology
|
14.32%
|
O:
-0.41%
H:
0.67%
C:
-0.23%
BIO
|
$278.59
-2.34%
110K
|
Health Technology
|
-8.33%
|
O:
-0.71%
H:
0.05%
C:
-0.6%
BDX
|
$233.97
-0.17%
420K
|
Health Technology
|
-1.9%
|
O:
-0.1%
H:
0.73%
C:
0.08%
ABT
|
News
|
$106.96
-0.59%
2.6M
|
Health Technology
|
4.65%
|
O:
-0.2%
H:
0.85%
C:
0.11%
VCYT
|
News
|
$19.93
0.5%
180K
|
Health Technology
|
-24.28%
|
O:
-0.95%
H:
2.93%
C:
1.66%
QGEN
|
$41.48
-0.98%
530K
|
Health Technology
|
2.34%
|
O:
0.37%
H:
0.46%
C:
-1.1%
NEO
|
$13.92
-1.7%
270K
|
Health Services
|
-26.56%
|
O:
-0.16%
H:
0.21%
C:
-1.14%
MYGN
|
$18.75
0.81%
150K
|
Health Technology
|
3.22%
|
O:
-0.55%
H:
1.45%
C:
0.5%
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
26.56%
|
O:
-1.5%
H:
0.97%
C:
-2.28%
HOLX
|
$76.98
-0.27%
340K
|
Health Technology
|
7.6%
|
O:
-0.42%
H:
0.43%
C:
0.13%
expected
reach
cancer
research
growing
market
Global Biopsy Devices Market Projected to Reach $11.86 Billion by 2027, Fueled by Rising Cancer Incidence and Advanced Diagnostic Procedures
Published:
2023-11-10
(Crawled : 01:00)
- prnewswire.com
TMO
|
News
|
$573.21
-0.24%
940K
|
Health Technology
|
23.59%
|
O:
-3.09%
H:
0.0%
C:
0.0%
SYK
|
$337.57
0.79%
690K
|
Health Technology
|
23.66%
|
O:
0.3%
H:
1.31%
C:
0.72%
MDT
|
$80.37
-1.13%
2.6M
|
Health Technology
|
15.98%
|
O:
0.49%
H:
0.57%
C:
0.35%
CNMD
|
$70.34
-1.36%
370K
|
Health Technology
|
-26.27%
|
O:
0.21%
H:
1.91%
C:
1.65%
CAH
|
$103.33
-0.04%
1M
|
Distribution Services
|
-0.34%
|
O:
0.26%
H:
1.46%
C:
1.01%
BSX
|
$73.295
6.24%
8.1M
|
Health Technology
|
34.14%
|
O:
0.43%
H:
0.41%
C:
-0.17%
BIO
|
$278.59
-2.34%
110K
|
Health Technology
|
-7.01%
|
O:
-0.27%
H:
0.44%
C:
-0.63%
BDX
|
$233.97
-0.17%
420K
|
Health Technology
|
0.91%
|
O:
0.68%
H:
0.8%
C:
0.35%
A
|
$137.51
-1.21%
720K
|
Health Technology
|
27.92%
|
O:
-1.1%
H:
0.0%
C:
0.0%
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
16.34%
|
O:
-12.11%
H:
4.83%
C:
4.63%
CNMD
|
$70.34
-1.36%
370K
|
Health Technology
|
-26.27%
|
O:
0.21%
H:
1.91%
C:
1.65%
diagnostic
reach
cancer
global
market
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published:
2023-11-03
(Crawled : 10:00)
- globenewswire.com
TSBX
|
$3.0
-1.96%
35K
|
|
-6.99%
|
O:
-9.73%
H:
17.85%
C:
8.42%
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
10.87%
|
O:
2.41%
H:
2.97%
C:
1.7%
tumors
cancer
preclinical
immunotherapy
meeting
potential
therapy
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
Published:
2023-10-20
(Crawled : 14:30)
- prnewswire.com
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
6.41%
|
O:
0.15%
H:
0.0%
C:
0.0%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-32.1%
|
O:
-1.85%
H:
3.14%
C:
-2.52%
MYGN
|
$18.75
0.81%
150K
|
Health Technology
|
26.88%
|
O:
0.41%
H:
3.13%
C:
2.38%
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
3.73%
|
O:
0.02%
H:
0.94%
C:
-0.3%
BNTX
|
News
|
$88.185
-0.35%
140K
|
Health Technology
|
-5.09%
|
O:
-1.46%
H:
0.48%
C:
-1.06%
companies
biotech
cancer
pancreatic
treatment
research
Global Pancreatic Cancer Diagnostic Market Set to Reach USD 3.90 Billion by 2030 with a CAGR of 6.53%
Published:
2023-10-17
(Crawled : 00:00)
- prnewswire.com
PHG
|
News
|
$20.92
-0.43%
350K
|
Health Technology
|
10.46%
|
O:
-2.21%
H:
0.7%
C:
-0.32%
A
|
$137.51
-1.21%
720K
|
Health Technology
|
26.72%
|
O:
1.06%
H:
0.0%
C:
0.0%
MYGN
|
$18.75
0.81%
150K
|
Health Technology
|
24.75%
|
O:
-1.01%
H:
2.44%
C:
2.03%
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
-5.62%
|
O:
-1.46%
H:
0.11%
C:
-4.23%
diagnostic
reach
cancer
pancreatic
global
set
market
Redefining Colorectal Cancer (CRC) Landscape Report with DLI's Epidemiology Study, Drug Insights, Price Reimbursement, and Regulatory Consulting Services | Disease Landscape Insights
Published:
2023-10-09
(Crawled : 10:00)
- prnewswire.com
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
-11.11%
|
O:
-0.99%
H:
0.56%
C:
-0.61%
EXAS
|
$64.075
0.86%
420K
|
Health Technology
|
1.32%
|
O:
-0.29%
H:
3.53%
C:
3.1%
drug
disease
services
report
cancer
Global Next Generation Cancer Diagnostics Market Research Report 2023-2030: Key Players are Focusing on Innovative Product Launches and Geographical Expansion to Maintain their Competitive Edge
Published:
2023-10-06
(Crawled : 09:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
-0.93%
|
O:
-0.72%
H:
0.0%
C:
-0.52%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
2.82%
|
O:
0.95%
H:
0.41%
C:
0.08%
PHG
|
News
|
$20.92
-0.43%
350K
|
Health Technology
|
6.6%
|
O:
-9.44%
H:
2.86%
C:
2.46%
A
|
$137.51
-1.21%
720K
|
Health Technology
|
24.83%
|
O:
-1.81%
H:
2.08%
C:
1.05%
OPK
|
$1.225
-2.0%
4.2M
|
Health Technology
|
-17.22%
|
O:
-1.32%
H:
2.68%
C:
2.01%
MYGN
|
$18.75
0.81%
150K
|
Health Technology
|
20.08%
|
O:
-0.97%
H:
4.4%
C:
-0.59%
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
-10.74%
|
O:
-1.36%
H:
2.95%
C:
1.8%
report
cancer
expansion
research
global
diagnostics
market
Illumina and Pillar Biosciences partner to improve access to personalized cancer treatment options
Published:
2023-07-25
(Crawled : 14:00)
- biospace.com/
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
-33.82%
|
O:
-1.1%
H:
3.49%
C:
1.8%
cancer
treatment
Real-world study data reveals better outcomes for cancer patients who receive comprehensive genomic testing
Published:
2023-05-30
(Crawled : 17:00)
- biospace.com/
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
-36.46%
|
O:
0.15%
H:
1.16%
C:
-0.86%
genomic
cancer
study
GRAIL Presents Positive Analytical Validation Data on its Methylation-Based Post-Diagnostic Cancer Research Solution at American Association for Cancer Research (AACR) Annual Meeting 2023
Published:
2023-04-19
(Crawled : 21:00)
- biospace.com/
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
-45.48%
|
O:
-1.0%
H:
2.76%
C:
2.48%
association
solution
positive
cancer
research
meeting
GRAIL Presents New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment at American Association for Cancer Research (AACR) Annual Meeting 2023
Published:
2023-04-17
(Crawled : 23:00)
- biospace.com/
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
-45.41%
|
O:
0.45%
H:
0.5%
C:
0.41%
AZN
|
News
|
$71.26
0.58%
3.8M
|
Health Technology
|
-4.08%
|
O:
-0.14%
H:
0.08%
C:
-0.18%
association
cancer
treatment
research
meeting
The Global Cancer Biomarkers Market to Upsurge at a Tremendous CAGR of ~14% by 2027 | DelveInsight
Published:
2023-02-13
(Crawled : 16:00)
- prnewswire.com
QGEN
|
$41.48
-0.98%
530K
|
Health Technology
|
-14.88%
|
O:
-1.34%
H:
1.01%
C:
0.6%
BIO
|
$278.59
-2.34%
110K
|
Health Technology
|
-39.45%
|
O:
0.45%
H:
0.68%
C:
-0.29%
ABBV
|
News
|
$168.21
-0.78%
1.2M
|
Health Technology
|
11.5%
|
O:
-0.02%
H:
1.16%
C:
1.12%
ABT
|
News
|
$106.96
-0.59%
2.6M
|
Health Technology
|
-0.53%
|
O:
0.15%
H:
0.76%
C:
0.18%
SNY
|
News
|
$46.765
-1.94%
950K
|
Health Technology
|
-1.18%
|
O:
-1.53%
H:
0.0%
C:
0.0%
QGEN
|
$41.48
-0.98%
530K
|
Health Technology
|
-14.88%
|
O:
-1.34%
H:
1.01%
C:
0.6%
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
-36.69%
|
O:
0.17%
H:
9.75%
C:
9.66%
HOLX
|
$76.98
-0.27%
340K
|
Health Technology
|
-5.7%
|
O:
0.23%
H:
1.74%
C:
1.72%
EXAS
|
$64.075
0.86%
420K
|
Health Technology
|
-0.81%
|
O:
0.55%
H:
1.69%
C:
1.57%
CNTG
|
$0.475
-1.04%
15K
|
Commercial Services
|
-62.79%
|
O:
0.0%
H:
3.88%
C:
-1.55%
global
biomarkers
cancer
market
GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection
Published:
2022-11-17
(Crawled : 22:00)
- biospace.com/
ILMN
|
$122.25
-1.78%
400K
|
Health Technology
|
-46.3%
|
O:
-2.93%
H:
2.02%
C:
-0.14%
dna
cancer
← Previous
1
2
3
4
Next →
Gainers vs Losers
58%
42%
Top 10 Gainers
CZOO
|
$10.52
110.82%
10M
|
CSSE
4
|
$0.3181
108.86%
170M
|
Consumer Services
BOF
|
$1.88
60.68%
98M
|
AMST
|
$3.1
55.0%
66M
|
Technology Services
LICN
|
$0.85
51.79%
13M
|
WIMI
|
$1.03
41.99%
15M
|
Technology Services
SKIL
4
|
$8.045
40.89%
230K
|
Information
MULN
|
News
|
$3.805
39.38%
11M
|
Information
RILY
|
$30.01
38.17%
11M
|
Finance
MTC
|
$3.04
35.71%
6.7M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.